Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Infusional C-myb ASODN in Advanced Hematologic Malignancies (UPCC 04701)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00780052
First received: October 24, 2008
Last updated: September 23, 2016
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)